Market Capitalization of Brooks Laboratories (BROOKS)
As of April 15, 2026, Brooks Laboratories (BROOKS) market capitalisation is ₹205.99 Cr ($22.89M), with 2.86 Cr shares outstanding at a current price of ₹72.07 on NSE, ranking 2534 out of 5363 companies by market cap in our screener. Brooks Laboratories operates in the Healthcare sector and is classified as a Small Cap stock. Compare with Brooks Laboratories value estimation to assess whether the stock is under or overvalued.
Market Cap History of Brooks Laboratories (Last 10 Years)
BROOKS market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Brooks Laboratories screener.
End of Year Market Cap History — Brooks Laboratories
BROOKS year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. View BROOKS price range for the annual high/low range and current price position.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹205.99 Cr
$22.89M USD
|
₹72.07 | NSE | -10.07% |
| 2025 |
₹229.06 Cr
$25.45M USD
|
₹80.14 | NSE | -56.67% |
| 2024 |
₹528.62 Cr
$58.74M USD
|
₹184.95 | BSE | +28.39% |
| 2023 |
₹411.72 Cr
$45.75M USD
|
₹144.05 | BSE | +33.02% |
| 2022 |
₹309.51 Cr
$34.39M USD
|
₹108.29 | BSE | +9.57% |
| 2021 |
₹282.48 Cr
$31.39M USD
|
₹98.83 | BSE | +50.17% |
| 2020 |
₹188.10 Cr
$20.90M USD
|
₹65.81 | BSE | +128.35% |
| 2019 |
₹82.37 Cr
$9.15M USD
|
₹28.82 | BSE | -51.85% |
| 2018 |
₹171.09 Cr
$19.01M USD
|
₹59.86 | BSE | -46.89% |
| 2017 |
₹322.12 Cr
$35.79M USD
|
₹112.70 | BSE | -14.94% |
| 2016 |
₹378.71 Cr
$42.08M USD
|
₹132.50 | BSE | +45.03% |
| 2015 |
₹261.12 Cr
$29.01M USD
|
₹91.36 | BSE | +105.26% |
| 2014 |
₹127.22 Cr
$14.14M USD
|
₹44.51 | BSE | +125.25% |
| 2013 |
₹56.48 Cr
$6.28M USD
|
₹19.76 | BSE | -10.10% |
| 2012 |
₹62.82 Cr
$6.98M USD
|
₹21.98 | BSE | +73.34% |
| 2011 |
₹36.24 Cr
$4.03M USD
|
₹12.68 | BSE | - |